Fred E Cooperrider
Examiner (ID: 11124)
Most Active Art Unit | 2723 |
Art Unit(s) | 2723, 2623 |
Total Applications | 39 |
Issued Applications | 33 |
Pending Applications | 2 |
Abandoned Applications | 4 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10214799
[patent_doc_number] => 20150099792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'ANTISENSE MODULATION OF GCGR EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 14/484638
[patent_app_country] => US
[patent_app_date] => 2014-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45201
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484638
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/484638 | Antisense modulation of GCGR expression | Sep 11, 2014 | Issued |
Array
(
[id] => 11457370
[patent_doc_number] => 20170051277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'ANTISENSE OLIGOMERS AND METHODS FOR TREATING SMN-RELATED PATHOLOGIES'
[patent_app_type] => utility
[patent_app_number] => 15/021642
[patent_app_country] => US
[patent_app_date] => 2014-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17966
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021642
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/021642 | ANTISENSE OLIGOMERS AND METHODS FOR TREATING SMN-RELATED PATHOLOGIES | Sep 11, 2014 | Abandoned |
Array
(
[id] => 9995899
[patent_doc_number] => 09040497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-26
[patent_title] => 'Treatment and diagnosis of colon cancer'
[patent_app_type] => utility
[patent_app_number] => 14/480098
[patent_app_country] => US
[patent_app_date] => 2014-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21337
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14480098
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/480098 | Treatment and diagnosis of colon cancer | Sep 7, 2014 | Issued |
Array
(
[id] => 15883301
[patent_doc_number] => 10647983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Reducing nonsense-mediated mRNA decay
[patent_app_type] => utility
[patent_app_number] => 14/916561
[patent_app_country] => US
[patent_app_date] => 2014-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 21552
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916561
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/916561 | Reducing nonsense-mediated mRNA decay | Sep 3, 2014 | Issued |
Array
(
[id] => 15883301
[patent_doc_number] => 10647983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Reducing nonsense-mediated mRNA decay
[patent_app_type] => utility
[patent_app_number] => 14/916561
[patent_app_country] => US
[patent_app_date] => 2014-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 21552
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916561
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/916561 | Reducing nonsense-mediated mRNA decay | Sep 3, 2014 | Issued |
Array
(
[id] => 10968268
[patent_doc_number] => 20140371301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'TREATMENT OF TUMOR NECROSIS FACTOR RECEPTOR 2 (TNFR2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TNFR2'
[patent_app_type] => utility
[patent_app_number] => 14/477457
[patent_app_country] => US
[patent_app_date] => 2014-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25362
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14477457
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/477457 | Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2 | Sep 3, 2014 | Issued |
Array
(
[id] => 9910490
[patent_doc_number] => 20150065693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF VASCULAR OR CARDIAC VALVULAR CALCIFICATION COMPRISING DIPEPTIDYL PEPTIDASE-4 INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/473618
[patent_app_country] => US
[patent_app_date] => 2014-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5211
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14473618
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/473618 | Composition for prophylaxis or treatment of vascular or cardiac valvular calcification comprising dipeptidyl peptidase-4 inhibitor | Aug 28, 2014 | Issued |
Array
(
[id] => 11364384
[patent_doc_number] => 20170002359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'MODULATION OF PREKALLIKREIN (PKK) EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 14/915039
[patent_app_country] => US
[patent_app_date] => 2014-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 76740
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14915039
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/915039 | Modulation of prekallikrein (PKK) expression | Aug 27, 2014 | Issued |
Array
(
[id] => 13763963
[patent_doc_number] => 10174316
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Anti-connexin compounds targeted to connexins and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 14/467978
[patent_app_country] => US
[patent_app_date] => 2014-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 34773
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14467978
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/467978 | Anti-connexin compounds targeted to connexins and methods of use thereof | Aug 24, 2014 | Issued |
Array
(
[id] => 16892101
[patent_doc_number] => 11033628
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-15
[patent_title] => Targeting PAX2 for the treatment of breast cancer
[patent_app_type] => utility
[patent_app_number] => 14/464565
[patent_app_country] => US
[patent_app_date] => 2014-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 59
[patent_no_of_words] => 27600
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14464565
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/464565 | Targeting PAX2 for the treatment of breast cancer | Aug 19, 2014 | Issued |
Array
(
[id] => 9902133
[patent_doc_number] => 20150057334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 14/462510
[patent_app_country] => US
[patent_app_date] => 2014-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6575
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14462510
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/462510 | USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS | Aug 17, 2014 | Abandoned |
Array
(
[id] => 9865412
[patent_doc_number] => 20150045431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'METHODS OF TREATING A CARDIOVASCULAR DISORDER IN A SUBJECT ON APO-C3 MODULATING THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/453167
[patent_app_country] => US
[patent_app_date] => 2014-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16922
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14453167
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/453167 | METHODS OF TREATING A CARDIOVASCULAR DISORDER IN A SUBJECT ON APO-C3 MODULATING THERAPY | Aug 5, 2014 | Abandoned |
Array
(
[id] => 10968262
[patent_doc_number] => 20140371295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'METHODS AND COMPOSITIONS TO PROTECT AQUATIC INVERTEBRATES FROM DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/338378
[patent_app_country] => US
[patent_app_date] => 2014-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 42964
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14338378
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/338378 | Methods and compositions to protect aquatic invertebrates from disease | Jul 22, 2014 | Issued |
Array
(
[id] => 10799464
[patent_doc_number] => 20160145617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'COMPOSITIONS FOR MODULATING TAU EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 14/906047
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62300
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 47
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14906047
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/906047 | Compositions for modulating Tau expression | Jul 20, 2014 | Issued |
Array
(
[id] => 10784507
[patent_doc_number] => 20160130663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/904188
[patent_app_country] => US
[patent_app_date] => 2014-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14297
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904188
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/904188 | METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENT | Jul 10, 2014 | Abandoned |
Array
(
[id] => 10806824
[patent_doc_number] => 20160152982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'APTAMERS AGAINST GLIOMA CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/903973
[patent_app_country] => US
[patent_app_date] => 2014-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 6263
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903973
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/903973 | Aptamers against glioma cells | Jul 8, 2014 | Issued |
Array
(
[id] => 10947050
[patent_doc_number] => 20140350072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'NOVEL REPRESSOR ON IFN-LAMBDA PROMOTER AND SIRNA AGAINST ZEB1 AND BLIMP-1 TO INCREASE IFN-LAMBDA GENE ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/324717
[patent_app_country] => US
[patent_app_date] => 2014-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16318
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324717
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/324717 | Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity | Jul 6, 2014 | Issued |
Array
(
[id] => 10947052
[patent_doc_number] => 20140350073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'DOUBLE-STRANDED NUCLEIC ACID MOLECULE, CANCER CELL PROLIFERATION INHIBITOR AND PHARMACEUTICAL AGENT SUITABLE FOR PREVENTION OR TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/324803
[patent_app_country] => US
[patent_app_date] => 2014-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10288
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324803
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/324803 | Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer | Jul 6, 2014 | Issued |
Array
(
[id] => 9798968
[patent_doc_number] => 20150010912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'METHODS OF DETECTING TUMOR CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/323840
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 26083
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323840
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323840 | Methods of detecting tumor cells | Jul 2, 2014 | Issued |
Array
(
[id] => 10483633
[patent_doc_number] => 20150368652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'TREATMENT OF NEUROPATHIC PAIN'
[patent_app_type] => utility
[patent_app_number] => 14/312152
[patent_app_country] => US
[patent_app_date] => 2014-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 28037
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312152
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/312152 | Treatment of neuropathic pain | Jun 22, 2014 | Issued |